STAQ Pharma's portfolio includes sterile compounded medications in categories such as syringes, nasal sprays, IV bags, and closed system transfer device kits.
STAQ Pharma's newsroom features press releases, media coverage, and product launch announcements.
Team
1 page
Paul Lisska/about/about-staq-pharma-2-2/patrick-welsh-2-2
Paul Lisska is STAQ Pharma's vice president of manufacturing sciences and technology, overseeing engineering, validation, maintenance, and facilities operations. He has more than 12 years of experience in cGMP manufacturing environments.
STAQ Pharma was founded to address the need for compounded medications, especially sterile injectables, produced in a 503B outsourcing facility built to cGMP standards.
STAQ Pharma says both its outsourcing facilities were designed and built to cGMP standards. Its Denver facility was developed to address a gap in pharmaceutical supply chain resilience.
STAQ Pharma is an FDA-registered 503B outsourcing partner that provides critical medications for pediatric and adult patients across the country. The company is hospital-backed and directed and is positioned to strengthen the supply chain for drug shortages.